ARCHIVES

Underpowered Study Of Evacet Dashes Approval Hopes

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

Nurse Oncology Society Growing, developing Care Guidelines

August 19, 1977

DCT Board Approves Two RFAs, Changes One To PA, Kills One On Liposomes

June 10, 1988

Preliminary Study Results Show DES In Utero Exposure May Not Be Threat Originally Feared

February 17, 1978